COMP <GO>
IREN vs JPM // 10Y YIELD & FRED MACRO BETA
IREN Limited (NASDAQ) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: IREN 4
— JPM 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: IREN
LAST: $26.25 (-8.98%) • MKT CAP: $10.62B
macro-sensitivity
1.08
LAST: $343.58 (+1.26%) • MKT CAP: $913.30B
macro-sensitivity
1.00
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.20% | 17.37% | -16.17 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 9.7x | +8.63 | JPM | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | -18.14% | +15.06 | IREN | /fcf-yield <GO> |
| Operating Margin | 3.50% | 42.07% | -38.57 | JPM | /operating-margins <GO> |
| Net Profit Margin | 17.40% | 32.63% | -15.23 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | 13.53% | +154.17 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.96% | -1.96 | JPM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.84% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.3 | 55.1 | -17.80 | JPM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 1.00 | +0.08 | IREN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 102.6x | 13.6x | +89.03 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.62B | $913.30B | -$902.68B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | JPM REV | IREN GROSS % | JPM GROSS % | IREN FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $182.45B | 68.3% | — | -$327.6M | -$147.78B |
| FY 2024 | $187.2M | $177.56B | 53.5% | — | -$89.6M | -$42.01B |
| FY 2023 | $75.5M | $158.10B | — | — | $2.3M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
JPM // BETA 1.00